Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-10-28FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a fixed-dose combination of losartan potassium and hydrochlorothiazide.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Effect of a Polyphenol Rich Diet on Vascular and Platelet Function [NA]
A completed clinical study evaluating whether a polyphenol-rich diet influences vascular and platelet function in individuals with hypertens…
-
FDA approval · 2015-10-27FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for the valsartan and hydrochlorothiazide combination from Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-10-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (Actavis Pharma, Inc.), a generic product.
-
FDA approval · 2015-10-26FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for losartan potassium from Alembic Pharmaceuticals Limited under the ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension
This completed clinical trial studies renin and aldosterone levels in preterm neonates at risk for hypertension.
-
CLINICAL_TRIALS research · 2015-10-20Clinical Trial Update: Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians [NA]
ClinicalTrials.gov entry for a dietary DASH-style approach to lowering blood pressure through sodium reduction in Chinese Canadian participa…
-
FDA approval · 2015-10-19FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
The FDA approved Epic Pharma, LLC's supplemental application for amlodipine besylate, enabling a generic version of amlodipine besylate to b…
-
FDA approval · 2015-10-19FDA Approved: TELMISARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for telmisartan from Mylan Pharmaceuticals, authorizing the generic telmisartan product's continued …
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Single Session of Active Video Game Promotes Post Exercise Hypotension in Middle-aged Hypertensive [NA]
A single session of an active video game was associated with post-exercise hypotension in middle-aged adults with hypertension, according to…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Green Tea Attenuates Pressure Reduction Induced by a Session of Physical Exercise [NA]
The trial evaluated whether green tea intake affects the blood pressure reduction observed after a session of physical exercise in people wi…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating the effectiveness and tolerability of MK-8141 in adults with hypertension…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter [NA]
A completed clinical trial investigated the use of a radiofrequency angioplasty catheter to treat resistant hypertension, with results poste…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Hypertension and Urine Protease Activity in Preeclampsia [NA]
A completed clinical trial studied hypertension and urine protease activity in preeclampsia.
-
FDA approval · 2015-10-15FDA Approved: IRBESARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for IRBESARTAN (irbesartan), indicating an approved change to the generic p…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of aliskiren in children aged 6 to 17 with hypertension; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk [Phase 2]
Phase 2 clinical trial evaluating interventions to improve hypertension control and reduce cardiovascular risk; the study status is complete…
-
FDA approval · 2015-10-14FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical's supplemental application for losartan potassium.
-
FDA approval · 2015-10-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Verapamil Hydrochloride (generic) from Chartwell RX, LLC.
-
FDA approval · 2015-10-14FDA Approved: LOSARTAN POTASSIUM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for a generic losartan potassium tablet by Unichem Pharmaceuticals (USA), Inc. for hypertension and re…
-
FDA label_change · 2015-10-13FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride by Actavis Pharma, Inc., indicating changes to the approved product …
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: The Effect of a Scratch Off Prompt on Health Engagement [NA]
University of Pennsylvania-sponsored trial completed a study on whether a scratch-off prompt influences engagement with health screening for…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients [Phase 2]
Phase 2 safety and efficacy study of BMS-823778 for uncontrolled hypertension in overweight/obese patients was terminated.
-
FDA approval · 2015-10-08FDA Approved: TELMISARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's supplemental application for telmisartan, enabling marketing of the generic product.
-
CLINICAL_TRIALS research · 2015-10-08Clinical Trial Update: Family Blood Pressure Program - HyperGEN
The HyperGEN family blood pressure trial has completed, focusing on hypertension and related cardiovascular conditions in families.